In summary, CHRM3, GABBR1, CCR4, KCNN4, PRKCE, and CYP2C9 are potential toxicological targets for BPA-induced ccRCC, providing a basis for future prevention and treatment strategies. The gene discussed is CYP2C9; the disease is nonpapillary renal cell carcinoma.